Literature DB >> 11112095

Mechanism of enhancement by fucoidan and CNBr-fibrinogen digest of the activation of glu-plasminogen by tissue plasminogen activator.

E Muneer1, J Bell, V M Doctor.   

Abstract

The interactions of fucoidan with human glutamic type plasminogen (Glu-Plg), porcine pancreatic elastase digested plasminogen fractions and two chain tissue plasminogen activator t-PA) were investigated using fucoidan-Sepharose affinity chromatography. The results showed a high degree of affinity between fucoidan-Sepharose and Glu-Plg or PlgK(1-3) but not with PlgK4 or mini-Plg. Fucoidan-Sepharose also showed a high affinity for t-PA, which was largely reversed by 0.002 M 6-aminohexanoic acid (6-AH). The addition of fucoidan and CNBr-fibrinogen digest (CNBr-Fbg) gave the highest enhancement of the in vitro activation of Glu-Plg by t-PA in the presence of 0.002 M 6-AH. The results of affinity chromatography and enhancement studies suggested a template mechanism, since increasing the concentrations of any one of the two cofactors reversed the enhancement. Enzyme kinetic studies, using double reciprocal plots, showed that the addition of fucoidan-6-AH increased Kcat by 7-fold without affecting Km and addition of CNBr-Fbg lowered Km by 5-fold without significantly affecting Kcat while addition of the two cofactors lowered Km by 16-fold without significantly affecting Kcat. The enhancement by fucoidan-6-AH or by CNBr-Fbg of the in vitro activation of Glu-Plg by t-PA was reversed by plasminogen activator inhibitor 1 (PAI-1). Fucoidan-Sepharose affinity chromatography revealed that the binding of PAI-1 with fucoidan may be responsible for the reversal of the enhancement by fucoidan-6-AH.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112095     DOI: 10.1007/BF03190080

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.569


  27 in total

1.  Isolation of anticoagulant fractions from crude fucoidin.

Authors:  G F SPRINGER; H A WURZEL; G M MCNEAL; N J ANSELL; M F DOUGHTY
Journal:  Proc Soc Exp Biol Med       Date:  1957-02

2.  Kinetic analysis of the effects of glycosaminoglycans and lipoproteins on urokinase-mediated plasminogen activation.

Authors:  J M Edelberg; M Weissler; S V Pizzo
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

3.  Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin.

Authors:  F C Church; J B Meade; R E Treanor; H C Whinna
Journal:  J Biol Chem       Date:  1989-02-25       Impact factor: 5.157

4.  Study on the mechanism of action of heparin and related substances on the fibrinolytic system: relationship between plasminogen activators and heparin.

Authors:  E P Pâques; H A Stöhr; N Heimburger
Journal:  Thromb Res       Date:  1986-06-15       Impact factor: 3.944

5.  On the action of a heparan-like glycosaminoglycan (Hemovasal) on the mechanism of haemostasis and fibrinolysis.

Authors:  K Zawilska; W Elikowski; Z Turowiecka; M Zozulinska; A Grzywacz; L Przybyl; H Vinazzer
Journal:  Thromb Res       Date:  1995-05-01       Impact factor: 3.944

6.  The specific interaction between plasminogen and fibrin. A physiological role of the lysine binding site in plasminogen.

Authors:  B Wiman; P Wallén
Journal:  Thromb Res       Date:  1977-02       Impact factor: 3.944

7.  Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator.

Authors:  C Zamarron; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1984-02-25       Impact factor: 5.157

8.  Interaction of plasminogen and fibrin in plasminogen activation.

Authors:  H L Wu; B I Chang; D H Wu; L C Chang; C C Gong; K L Lou; G Y Shi
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

9.  Quantitative determination of the binding of epsilon-aminocaproic acid to native plasminogen.

Authors:  G Markus; J L DePasquale; F C Wissler
Journal:  J Biol Chem       Date:  1978-02-10       Impact factor: 5.157

10.  Effects of heparan sulfate analogue or other sulfated polysaccharides on the activation of plasminogen by t-PA or u-PA.

Authors:  Y Takada; T Urano; A Takada
Journal:  Thromb Res       Date:  1994-03-01       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.